Shares of DNA testing firm 23andMe were in free fall on Monday after it filed for Chapter 11 bankruptcy protection and lost ...

The bankruptcy of 23andMe highlights a lack of protections for genetic privacy in the U.S.

Me might have filed for bankruptcy, but the transformation it brought to health care over nearly two decades is irreversible, ...

In a shocking development for investors and fans of genetic testing, 23andMe (ME) shares are plummeting, set to open around $1 this Monday morning after the company filed for Chapter 11 bankruptcy.

Me, once a leader in genetic testing, has filed for Chapter 11 bankruptcy and is actively seeking a buyer after its stock ...

Genetic testing company 23andMe has filed for bankruptcy after struggling with financial difficulties and strategic missteps.

Genetic testing company 23andMe said it has begun bankruptcy proceedings, seeking to maximize value through a ...

A Strategic Move? The Chapter 11 filing indicates that 23andMe will enter a court-supervised sale or auction of its assets. Mark Jensen, a board member, has stated that this is the "best path forward ...

If you were ever told or ever thought that giving your genetic data to a company like 23andMe is a bad idea, the company ...

DNA testing firm 23andMe has filed for Chapter 11 bankruptcy protection. The once high-flying San Francisco company—which provides DNA analysis to offer insights into ancestry, health traits ...

With genetic testing company 23andMe declaring bankruptcy and courting bidders, the DNA data of millions of users is up for ...